Results 41 to 50 of about 562 (137)

The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia [PDF]

open access: yes, 2016
© 2016, Media Sphera. All rights reserved.Objective. To study the impact of combination therapy with mexidol and cerebrolysin on the clinical status of patients with chronic cerebral ischemia (CCI), II stage, in ambulatory conditions.
Berezhnaya S., Yakupov E., Zaharov Y.
core  

Effect of the 60-day introduction of tartrazine and mexidol on the ultrastructure of the rat’s parathyroid gland chief cells

open access: yesИзвестия высших учебных заведений. Поволжский регион: Медицинские науки, 2023
Background. The purpose was to study the effect of long-term administration of tartrazine and mexidol on the ultramicroscopic structure of the chief cells of the parathyroid glands in rats. Materials and methods.
V.I. Luzin, V.N. Morozov
doaj   +1 more source

Paradoxical effects of antioxidant action in the photohaemolisis system [PDF]

open access: yes, 2016
The influence of Mexidol (solution for intravenous administration, “PHARMASOFT Ltd”.) in its therapeutic (0,24–3,9 μg/мл) and more high (15,6 μg/мл) concentrations on photo induced lysis (with Radachlorin, “RADAPHARMA Ltd”, as a photo sensitizer and a ...
Solovtsova, Irina L.   +4 more
core   +1 more source

The Effectiveness of Combined Use of Antioxidant and Glutamine in Abdominal Sepsis

open access: yesОбщая реаниматология, 2017
Aim of the study: the effectiveness of concomitant use of antioxidant therapy with antioxidant 2-ethyl-6- methyl-3-hydroxypyridine succinate (mexidol) and intensive nutritional support with glutamine in patients with abdominal sepsis (AS).
V. V. Nazaretyan   +2 more
doaj   +1 more source

Mexidol protection of the glutathione-derived enzyme system of the blood in experimental pulmonary emphysema

open access: yesInfusion & Chemotherapy
BACKGROUND. The paper presents an analysis of literature data on the glutathione-dependent enzyme system, the results of the authors' own studies on disorders in it, and the effect of mexidol in experimental pulmonary emphysema. OBJECTIVE.
Yu.I. Feshchenko   +5 more
doaj   +1 more source

Correction of cardiovascular disorders in diabetic patients with depressive simptoms

open access: yesКардиоСоматика, 2013
We studied the influence of mexidol and a-lipoic acid on cardiovascular and affective disorders' severity in patients with diabetes. 14-day administration of mexidol (300 mg/day) and a-lipoic acid (600 mg/day) had a positive impact on depressive guilt ...
M. I Kolyadich, I. I Shaposhnik
doaj  

Possibilities of antioxidant therapy for asthenia and cognitive deficit in elderly patients with chronic brain ischemia

open access: yesТерапевтический архив, 2013
AIM: To evaluate the effect of the antioxidant mexidol on the oxidant-antioxidant potential of low-density lipoprotein (LDL), asthenic and anxious symptoms, and cognitive function of neurodynamic type in elderly patients with chronic brain ischemia (CBI)/
S N Duma
doaj  

The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia

open access: yes, 2020
© 2016, Media Sphera. All rights reserved.Objective. To study the impact of combination therapy with mexidol and cerebrolysin on the clinical status of patients with chronic cerebral ischemia (CCI), II stage, in ambulatory conditions.
Berezhnaya S., Yakupov E., Zaharov Y.
core  

[The use of mexidol in chronic cerebral ischemia].

open access: yesZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2014
[No abstract available]
Lyang O.V., Kochetov A.G.
openaire   +2 more sources

Effect of Antioxidant Preparation «Mexidol» on the Protein Components of the Erythrocyte Cytoplasmic Membrane in Patients with Ulcerative Colitis [PDF]

open access: yes, 2020
Background. Ulcerative colitis is a colon disease accompanied by a systemic inflammatory response with the development of oxidative stress, which leads to structural and functional changes in cell membranes.
T. S. Yan'kova   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy